发明名称 |
Novel use |
摘要 |
The invention provides the use of a) an HIV Tat protein or polynucleotide; or b) an HIV Nef protein or polynucleotide; or c) an HIV Tat protein or polynucleotide linked to an HIV Nef protein or polynucleotide (Nef-Tat); and an HIV gp120 protein or polynucleotide in the manufacture of a vaccine for the prophylactic or therapeutic immunisation of humans against HIV.
|
申请公布号 |
US2005266025(A1) |
申请公布日期 |
2005.12.01 |
申请号 |
US20050119212 |
申请日期 |
2005.04.29 |
申请人 |
SMITHKLINE BEECHAM BIOLOGICALS, S.A. |
发明人 |
VOSS GERALD |
分类号 |
C12N15/09;A61K39/00;A61K39/12;A61K39/39;A61K48/00;A61P31/18;C07K14/16;C12N15/49;(IPC1-7):C07K14/16;A61K39/21 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|